EM

Eric Moessinger

at +ND Capital

Redwood City, California

Investor
VC

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Venture Capital
Private Equity
Start-ups
Due Diligence
Entrepreneurship
Strategy

Education

Lists including Eric

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

AT
AE
AE
AL

All Pre-Seed Investors

7974 people

Investments

Partillion Bioscience

Seed

Total Funding: $5M

SQZ Biotech

Series B

Total Funding: $160M

Inscripta

Series B

Total Funding: $260M

Serotiny

Seed

Total Funding: $3M

ARMO BioSciences

Series B

Total Funding: $170M

Emulate

Series A

Total Funding: $210M

Pulse Therapeutics

Series Unknown

Total Funding: $14M

Twist Bioscience

Series B

Total Funding: $170M

Work Experience

N
NanoDimension

2008

  • Partner

    2008

    NanoDimension is a venture capital firm investing in disruptive technologies at the convergence of the life, physical and data sciences. Focus on life science related investments at +ND. Joined in 2008 as the first employee of +ND’s Bay Area office. Currently serve on the board of directors of Emulate, Visby, Serotiny, Partillion and AIRNA, and observe on the boards of Inscripta, Lightcast and IonPath. Previously served as a board member at Icosavax (Nasdaq: ICVX) and SQZ (NYSE: SQZ), and observed on the board of ARMO (acquired by Lilly) and Twist (Nasdaq: TWST). Helped lead +ND’s investments in Orca and Octant.

B&
Bain & Company

2005 - 2008

  • Senior Associate Consultant

    2005 - 2008